Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants

Amal Elfatih(Translational Genomics Research Institute), Zohreh Tatari-Calderone(Oryzon Genomics (Spain)), Mashael Al‐Shafai(Qatar University), Heba Yasin(Universitas Palembang), Fazulur Rehaman Vempalli, Fatima Alkuwari, Younes Mokrab(Sidra Medical and Research Center), Tushar Pathare, Muhammad Arshad Alvi, Tariq Abu Zaid, Khalid A. Fakhro(Sidra Medical and Research Center), Souhaila Al Khodor(Qatar Airways (Qatar)), Nahla Afifi, Xavier Estivill(Barcelona Biomedical Research Park), Shafeeq Poolat, Karsten Suhre(Cornell University), Eleni Fthenou(Qatar Foundation), Fatima Qafoud, Stephan Lorenz, Yasser Al‐Sarraj(Hamad bin Khalifa University), Hakeem Almabrazi, Puthen V. Jithesh(Sidra Medical and Research Center), Chadi Saad(Qatar Foundation), Sara Tomei, Dima Darwish, Lotfi Chouchane(Cornell University), Hamdi Mbarek(King's College London), Najeeb Syed, Tariq Abu Saqri, Rania G. Abdel‐latif(Minia University), Ramzi Temanni(Sidra Medical and Research Center), Said I. Ismail(Qatar Foundation), Omar Albagha(Institute of Genetics and Cancer), Radja Badji, Tasnim Fadl, Mehshad Hamza, Maryem Ennaifar, Ramin Badii(Hamad Medical Corporation), Eiman Alkhayat, Wei Liu(Qatar Airways (Qatar)), Malak El Khatib(Qatar Airways (Qatar)), Asmaa Althani, Wadha Al‐Muftah, Rashid Al‐Ali(Sidra Medical and Research Center), Ahmed El Khouly
European Journal of Human Genetics
July 17, 2024
Cited by 22


Related Papers